Lenalidomide, Ibrutinib, and Rituximab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma That Is Metastatic or Cannot Be Removed by Surgery

Clinical trial NCT02160015 · ACTIVE_NOT_RECRUITING

Trial details

NCT number

NCT02160015

Sponsor

National Cancer Institute (NCI)

Status

ACTIVE_NOT_RECRUITING

Phase

Phase 1

Study type

INTERVENTIONAL

Start date

2014-05-20

Primary completion

2017-03-27

Enrollment

12

View on ClinicalTrials.gov